Many cancer treatments aim to target the dysregulated cell cycle. For example, CDK inhibitors are designed to block the activity of cyclin-dependent kinases, thereby halting the proliferation of cancer cells. Chemotherapy and radiation therapy often target rapidly dividing cells, exploiting the fact that cancer cells have lost normal cell cycle control and are more susceptible to these treatments.
